查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1347909

藥品品質管理系統市場：按解決方案類型、部署形式和最終用戶 - 到 2030 年的全球預測

Pharmaceutical Quality Management Systems Market by Solution Type, Deployment Mode, and End User - Global Forecast to 2030
出版日期: | 出版商: Meticulous Research | 英文 215 Pages | 訂單完成後即時交付

價格

製藥品質管理系統市場：按解決方案類型（出發、CAPA、審計、風險與合規性、檢查、文件、變更、培訓管理）、按部署類型（雲端、內部部署）、按最終用戶（製藥、 CDMO/CRO) - 2030 年之前的世界預測

到 2030 年，藥品品質管理系統市場預計將達到 39.7 億美元，2023 年至 2030 年的複合年增長率為 15.6%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告研究了關鍵行業的驅動因素、限制因素、挑戰和機會。 該市場的成長是由藥品製造成本不斷增加、製藥公司滿足監管要求的需求不斷增加、製藥業的快速成長以及基於軟體的品質管理系統的好處所推動的。 此外，仿製藥和生物製藥市場的成長以及製藥公司對平台即服務解決方案的日益偏好預計將為市場參與者提供成長機會。 然而，實施藥品品質控制系統的高昂成本限制了該市場的成長。 與製藥公司雲端部署相關的安全性問題對市場成長構成了重大挑戰。

目錄

第 1 章簡介

第 2 章研究方法

第 3 章執行摘要

第 4 章市場洞察

  • 摘要
  • 市場成長因素
    • 市場動態
      • 製藥公司滿足監管要求的需求日益增長，推動了製藥品質管理系統的採用
      • 實施藥品品質管制系統的成本高昂，限制了其採用
      • 不斷成長的仿製藥和生物製藥市場為市場參與者創造了成長機會
      • 與雲端實施相關的安全性問題影響製藥品質管理系統的實施
    • 因素分析
  • 趨勢
    • 將人工智慧和機器學習整合到藥品品質控制系統中
    • 對個人化醫療的渴望日益增長
  • 藥品品質管理系統市場監理分析
    • 摘要
    • 國際標準化組織 (ISO)
    • 藥品檢驗合作計畫（PIC/S）
    • ICH 指南 Q10
    • 現行良好生產規範 (cGMP)
  • 價格分析
  • 個案研究

第 5 章藥品品質管理系統市場：依解決方案類型評估

  • 摘要
  • 不合格/偏差管理
  • 文件管理
  • CAPA 管理
  • 風險與合規管理
  • 檢定管理
  • 審計管理
  • 供應商和物料管理
  • 訓練管理
  • 變革管理
  • 其他解決方案類型

第 6 章藥品品質管理系統市場評估：依實施模式

  • 摘要
  • 基於雲端/網路
  • 本地

第 7 章藥品品質管理系統市場評估：最終使用者

  • 摘要
  • 製藥和生技公司
  • 開發/製造合約組織/研究合約組織
  • 研究院

第 8 章藥品品質管理系統的市場評估：按最終使用者

  • 摘要
  • 醫院/診所
  • 診斷實驗室
  • 家庭醫療保健
  • 其他最終用戶

第 9 章藥品品質管理系統市場評估：依地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 愛爾蘭
    • 比利時
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 新加坡
    • 馬來西亞
    • 菲律賓
    • 越南
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東/非洲

第 10 章競爭分析

  • 摘要
  • 主要成長策略
  • 競爭基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 領先企業
    • 新興公司
  • 市場參與者排名（2022 年）

第 11 章公司簡介

  • Honeywell International Inc.
    • 公司簡介
    • 財務概覽
    • 解決方案組合
    • 策略發展
    • SWOT分析
  • IQVIA Holdings Inc.
    • 公司簡介
    • 財務概覽
    • 解決方案組合
    • SWOT分析
  • Dassault Systemes SE
    • 公司簡介
    • 財務概覽
    • 解決方案組合
    • 策略發展
    • SWOT分析
  • Korber AG
    • 公司簡介
    • 財務概覽
    • 解決方案組合
    • 策略發展
    • SWOT分析
  • ANTARES VISION S.p.A.
    • 公司簡介
    • 財務概覽
    • 解決方案組合
    • 策略發展
    • SWOT分析
  • EtQ Management Consultants Inc.（Hexagon AB 子公司）
    • 公司簡介
    • 財務概覽
    • 解決方案組合
  • Ideagen PLC（Rainforest Bidco Limited 的子公司）
    • 公司簡介
    • 財務概覽
    • 解決方案組合
    • 策略發展
  • AssurX, Inc.
    • 公司簡介
    • 解決方案組合
    • 策略發展
  • AXSource Consulting, Inc.
    • 公司簡介
    • 解決方案組合
    • 策略發展
  • ComplianceQuest, Inc.
    • 公司簡介
    • 解決方案組合
    • 策略發展
  • LogicGate, Inc.
    • 公司簡介
    • 產品組合
    • 策略發展
  • MasterControl Solutions Inc.
    • 公司簡介
    • 解決方案組合
    • 策略發展

（註：將提供前5名公司的SWOT分析）

第 12 章附錄

Product Code: MRHC - 104714

Pharmaceutical Quality Management Systems Market By Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO)-Global Forecast to 2030

The pharmaceutical quality management systems market is expected to reach $3.97 billion by 2030, at a CAGR of 15.6% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report studies the key industry drivers, restraints, challenges, and opportunities. The growth of this market is driven by the increasing costs of drug manufacturing, pharmaceutical companies growing need to comply with regulatory requirements, the rapid growth of the pharmaceutical industry, and the benefits of software-based quality management systems. Additionally, the growing generic drugs & and biopharmaceuticals markets and pharmaceutical companies' increasing preference for platform-as-a-service solutions are expected to generate growth opportunities for the players in this market. However, the high costs of deploying pharmaceutical quality management systems restrain the growth of this market. Security concerns related to on-cloud deployments among pharmaceutical organizations are a major challenge for market growth.

Based on solution type, the pharmaceutical quality management systems market is segmented into non-conformance/deviation management, CAPA management, audit management, risk & compliance management, suppliers & materials management, inspection management, document management, change management, training management, and other solution types. The CAPA management segment is expected to grow at the highest CAGR during the forecast period. The need for Corrective and Preventive Action (CAPA) management in the pharmaceutical industry is driven by several factors that ensure product quality, patient safety, and regulatory compliance. CAPA management is essential for addressing issues and preventing their recurrence, further contributing to the overall integrity of pharmaceutical operations.

Based on deployment mode, the global pharmaceutical quality management systems market is segmented into cloud/web-based and on-premise. In 2023, the cloud/web-based segment is expected to account for the largest share of the pharmaceutical quality management systems market. The largest share of this segment is attributed to several advantages offered by cloud/web-based deployments over on-premise deployments, such as cost minimization, easy accessibility, adjustability, and updated cloud systems. Another major advantage of web-based deployments is the lower risk of data loss through better encryption and data backup.

Based on end user, the global pharmaceutical quality management systems market is segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations/contract research organizations, and research laboratories. The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. The highest CAGR of the segment is attributed to increasing R&D investments by pharmaceutical & biotechnology companies, widespread utilization of quality management systems to ensure product quality, and a growing emphasis on personalized medicine research.

An in-depth analysis of the geographical scenario of the pharmaceutical quality management systems market provides detailed qualitative and quantitative insights into five major geographies: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, along with the coverage of major countries in each region. Asia-Pacific is slated to register with the highest CAGR during the forecast period. The healthcare needs of people in Asia-Pacific countries are progressively increasing due to the rising burden of chronic diseases. A large population pool and government initiatives to improve healthcare facilities and services in these countries are the key factors supporting the growth of the Asia-Pacific market. These countries have also been identified as low-cost destinations for pharmaceutical manufacturers for a long time, which further supports the growth of this market in Asia-Pacific.

Some of the key players operating in the global pharmaceutical quality management systems market are Honeywell International Inc. (U.S.), IQVIA Holdings Inc. (U.S.), ANTARES VISION S.p.A (Italy), Dassault Systemes SE (France), EtQ Management Consultants, Inc. (U.S.), Ideagen PLC (U.K.), Korber AG (Germany), LogicGate, Inc. (U.S.), ComplianceQuest, Inc (U.S.), AssurX, Inc. (U.S.), and AXSource Consulting, Inc. (U.S.).

Scope of the Report:

Pharmaceutical Quality Management Systems Market Assessment by Solution Type

  • Non-conformance/Deviation management
  • Document Management
  • CAPA Management
  • Risk & Compliance Management
  • Inspection Management
  • Audit Management
  • Suppliers & Materials Management
  • Training Management
  • Change Management
  • Other Solution Types

(Other solution types include complaint management, out-of-specification, release management, incidents & and occurrence management, post-market surveillance, design control, and asset management.)

Pharmaceutical Quality Management Systems Market Assessment, by Deployment Mode

  • Cloud/Web-based
  • On-Premise

Pharmaceutical Quality Management Systems Market Assessment, by End User

  • Pharmaceutical and Biotechnology Companies
  • CDMO/CRO
  • Research Laboratories

Pharmaceutical Quality Management Systems Market Assessment, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Ireland
    • Belgium
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Singapore
    • Malaysia
    • Philippines
    • Vietnam
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Market Dynamics
      • 4.2.1.1. Pharmaceutical Companies' Growing Need to Comply with Regulatory Requirements Driving the Adoption of Pharmaceutical Quality Management Systems
      • 4.2.1.2. High Costs of Deploying Pharmaceutical Quality Management Systems Limiting their Adoption
      • 4.2.1.3. Growing Generic Drugs & Biopharmaceuticals Markets Generating Growth Opportunities for Market Players
      • 4.2.1.4. Security Concerns Related to On-cloud Deployments Impacting the Implementation of Pharmaceutical QMS
    • 4.2.2. Factor Analysis
  • 4.3. Trends
    • 4.3.1. Integration Of Artificial Intelligence & Machine Learning into Pharmaceutical Quality Management Systems
    • 4.3.2. Increasing Inclination Toward Personalized Medicine
  • 4.4. Pharmaceutical Quality Management Systems Market: Regulatory Analysis
    • 4.4.1. Overview
    • 4.4.2. International Organization for Standardization (ISO)
    • 4.4.3. Pharmaceutical Inspection Co-Operation Scheme (PIC/S)
    • 4.4.4. ICH Guideline Q10
    • 4.4.5. Current Good Manufacturing Practice (cGMP)
  • 4.5. Pricing Analysis
  • 4.6. Case Studies

5. Pharmaceutical Quality Management Systems Market Assessment-by Solution Type

  • 5.1. Overview
  • 5.2. Non-Conformance/Deviation Management
  • 5.3. Document Management
  • 5.4. CAPA Management
  • 5.5. Risk & Compliance Management
  • 5.6. Inspection Management
  • 5.7. Audit Management
  • 5.8. Suppliers & Materials Management
  • 5.9. Training Management
  • 5.10. Change Management
  • 5.11. Other Solution Types

6. Pharmaceutical Quality Management Systems Market Assessment-by Deployment Mode

  • 6.1. Overview
  • 6.2. Cloud/Web-based
  • 6.3. On Premise

7. Pharmaceutical Quality Management Systems Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Pharmaceutical And Biotechnology Companies
  • 7.3. Contract Development and Manufacturing Organization/ Contract Research Organization
  • 7.4. Research Laboratories

8. Pharmaceutical Quality Management Systems Market Assessment-by End User

  • 8.1. Overview
  • 8.2. Hospitals & Clinics
  • 8.3. Diagnostic Laboratories
  • 8.4. Home Healthcare
  • 8.5. Other End Users

9. Pharmaceutical Quality Management Systems Market Assessment-by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Ireland
    • 9.3.7. Belgium
    • 9.3.8. Netherlands
    • 9.3.9. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. Japan
    • 9.4.2. China
    • 9.4.3. India
    • 9.4.4. Singapore
    • 9.4.5. Malaysia
    • 9.4.6. Philippines
    • 9.4.7. Vietnam
    • 9.4.8. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Players Ranking (2022)

11. Company Profiles

  • 11.1. Honeywell International Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Solution Portfolio
    • 11.1.4. Strategic Developments
    • 11.1.5. SWOT Analysis
  • 11.2. IQVIA Holdings Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Solution Portfolio
    • 11.2.4. SWOT Analysis
  • 11.3. Dassault Systemes SE
    • 11.3.1. Company Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Solution Portfolio
    • 11.3.4. Strategic Developments
    • 11.3.5. SWOT Analysis
  • 11.4. Korber AG
    • 11.4.1. Company Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Solution Portfolio
    • 11.4.4. Strategic Developments
    • 11.4.5. SWOT Analysis
  • 11.5. ANTARES VISION S.p.A.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Overview
    • 11.5.3. Solution Portfolio
    • 11.5.4. Strategic Developments
    • 11.5.5. SWOT Analysis
  • 11.6. EtQ Management Consultants Inc. (A Subsidiary of Hexagon AB)
    • 11.6.1. Company Overview
    • 11.6.2. Financial Overview
    • 11.6.3. Solution Portfolio
  • 11.7. Ideagen PLC (A Subsidiary of Rainforest Bidco Limited)
    • 11.7.1. Company Overview
    • 11.7.2. Financial Overview
    • 11.7.3. Solution Portfolio
    • 11.7.4. Strategic Developments
  • 11.8. AssurX, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Solution Portfolio
    • 11.8.3. Strategic Developments
  • 11.9. AXSource Consulting, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Solution Portfolio
    • 11.9.3. Strategic Developments
  • 11.10. ComplianceQuest, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Solutions Portfolio
    • 11.10.3. Strategic Developments
  • 11.11. LogicGate, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Product Portfolio
    • 11.11.3. Strategic Developments
  • 11.12. MasterControl Solutions Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Solution Portfolio
    • 11.12.3. Strategic Developments

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports
  • Table 1 Recent Biopharmaceutical Plant Capacity Expansions
  • Table 2 Overview of Product Lifecycle Stages
  • Table 3 Overview of Standards and Compliance Guidelines Related to Pharmaceutical Quality Management Systems
  • Table 4 GMP Regulations
  • Table 5 Pharmaceutical Quality Management Software: Pricing
  • Table 6 Global Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 7 Global Non-Conformance/Deviation Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 8 Global Document Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global CAPA Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 10 Global Risk & Compliance Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Inspection Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Audit Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Suppliers & Materials Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Training Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Change Management Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global Other Solution Types Market, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 18 Global Cloud/Web-Based Pharmaceutical Quality Management Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global On-Premise Pharmaceutical Quality Management Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 21 Global Pharmaceutical Quality Management Systems Market for Pharmaceutical and Biotechnology Companies, by Country/Region, 2021-2030 (USD Million)
  • Table 22 Global Pharmaceutical Quality Management Systems Market For CDMO/CRO, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Pharmaceutical Quality Management Systems Market for Research Laboratories, by Country/Region, 2021-2030 (USD Million)
  • Table 24 Global Pharmaceutical Quality Management Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 25 North America: Pharmaceutical Quality Management Systems Market, by Country, 2021-2030 (USD Million)
  • Table 26 North America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 27 North America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 28 North America: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 29 U.S.: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 30 U.S.: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 31 U.S.: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 32 Canada: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 33 Canada: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 34 Canada: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 35 Europe: Pharmaceutical Quality Management Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Europe: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 37 Europe: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 38 Europe: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 39 Germany: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 40 Germany: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 41 Germany: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 42 France: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 43 France: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 44 France: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 45 U.K.: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 46 U.K.: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 47 U.K.: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 48 Italy: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 49 Italy: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 50 Italy: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 51 Spain: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 52 Spain: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 53 Spain: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 54 Ireland: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 55 Ireland: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 56 Ireland: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 57 Belgium: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 58 Belgium: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 59 Belgium: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 60 Netherlands: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 61 Netherlands: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 62 Netherlands: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 63 Rest of Europe: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 64 Rest of Europe: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 65 Rest of Europe: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 66 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 67 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 68 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 69 Asia-Pacific: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 70 China: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 71 China: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 72 China: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 73 Japan: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 74 Japan: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 75 Japan: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 76 India: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 77 India: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 78 India: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 79 Singapore: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 80 Singapore: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 81 Singapore: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 82 Malaysia: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 83 Malaysia: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 84 Malaysia: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 85 Philippines: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 86 Philippines: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 87 Philippines: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 88 Vietnam: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 89 Vietnam: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 90 Vietnam: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 91 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 92 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 93 Rest of Asia-Pacific: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 94 Latin America: Pharmaceutical Quality Management Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 95 Latin America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 96 Latin America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 97 Latin America: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 98 Brazil: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 99 Brazil: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 100 Brazil: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 101 Mexico: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 102 Mexico: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 103 Mexico: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 104 Rest of Latin America: Regulatory Agencies for Pharmaceutical Quality Management Systems
  • Table 105 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 106 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 107 Rest of Latin America: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 108 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by Solution Type, 2021-2030 (USD Million)
  • Table 109 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by Deployment Mode, 2021-2030 (USD Million)
  • Table 110 Middle East & Africa: Pharmaceutical Quality Management Systems Market, by End User, 2021-2030 (USD Million)
  • Table 111 Recent Developments, by Company, 2020-2023
  • Table 112 Pharmaceutical Quality Management Systems Market: Competitive Benchmarking by Solution